SCHEMBL3463475

SCHEMBL3463475

NCCC(N)Cc1c2ccccc2cc2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.46
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
HRH1 P35367 1/20 0.35
LOXL2 Q9Y4K0 1/20 0.35
HTR1B P28222 1/20 0.35
POLB P06746 2/20 0.34
HPGD P15428 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HIF1A Q16665 1/20 0.33
CYP1B1 Q16678 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
EDNRA P25101 1/20 0.33
SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3290867 0.88 HTR2A (0.50) HTR2AL3MBTL1ALDH1A1KDM4EGAA
Hydrochloric Acid SCHEMBL3293875 0.85 HTR2A (0.47) HTR2AL3MBTL1ALDH1A1KDM4EHTR1B
SCHEMBL23979280 0.76 HTR2A (0.55) HTR2AL3MBTL1TAAR1HTR1BSLC6A2
SCHEMBL3291640 0.74 HTR2A (0.46) HTR2AL3MBTL1ALDH1A1KDM4EGAA
SCHEMBL1264432 0.72 HTR2A (0.68) HTR2AL3MBTL1ALDH1A1KDM4EGAA
SCHEMBL29758941 0.72 HTR2A (1.00) HTR2AL3MBTL1ALDH1A1KDM4EGAA
SCHEMBL2384515 0.72 HTR2A (1.00) HTR2AL3MBTL1ALDH1A1KDM4EGAA
SCHEMBL4934813 0.72 HTR2A (0.36) HTR2AL3MBTL1
SCHEMBL7206758 0.71 HTR2A (0.50) HTR2AL3MBTL1ALDH1A1KDM4EGAA
SCHEMBL7206762 0.71 HTR2A (0.50) HTR2AL3MBTL1ALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240747-A1 Motuporamine Mimic Agents PHANSTIEL OTTO 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240747-A1 Motuporamine Mimic Agents MYADM, CD99, HNMT HTR2A 3629/4885L3MBTL1 2015/4885ALDH1A1 2127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.